Search Results

RNA-based therapies targeting APOC3 lower triglyceride levels in patients with hypertriglyceridaemia.

• Authors : Huynh K; Nature Reviews Cardiology, . .

Subjects: Hypertriglyceridemia*/Hypertriglyceridemia*/Hypertriglyceridemia*/blood ; Hypertriglyceridemia*/Hypertriglyceridemia*/Hypertriglyceridemia*/therapy ; Hypertriglyceridemia*/Hypertriglyceridemia*/Hypertriglyceridemia*/drug therapy

• Source: Nature reviews. Cardiology [Nat Rev Cardiol] 2024 Jun; Vol. 21 (6), pp. 353.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500075 Publication Model: Print Cited Medium: Internet ISSN: 1759-5010

Record details

Gene therapy. Inhibiting apoC-III synthesis in patients with hypertriglyceridaemia.

• Authors : Huynh K

Subjects: Apolipoprotein C-III/Apolipoprotein C-III/Apolipoprotein C-III/*antagonists & inhibitors ; Hypertriglyceridemia/Hypertriglyceridemia/Hypertriglyceridemia/*drug therapy ; Oligonucleotides/Oligonucleotides/Oligonucleotides/*administration & dosage

• Source: Nature reviews. Cardiology [Nat Rev Cardiol] 2015 Oct; Vol. 12 (10), pp. 562. Date of Electronic Publication: 2015 Aug 18.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500075 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Gene therapy: Targeting apoc-III to lower triglycerides.

• Authors : Huynh K

Subjects: Apolipoprotein C-III/Apolipoprotein C-III/Apolipoprotein C-III/*antagonists & inhibitors ; Hyperlipoproteinemia Type I/Hyperlipoproteinemia Type I/Hyperlipoproteinemia Type I/*drug therapy ; Lipoprotein Lipase/Lipoprotein Lipase/Lipoprotein Lipase/*deficiency

• Source: Nature reviews. Cardiology [Nat Rev Cardiol] 2015 Feb; Vol. 12 (2), pp. 64. Date of Electronic Publication: 2014 Dec 23.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500075 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Genetics. APOC3 mutations lower CVD risk.

• Authors : Geach T

Subjects: Mutation*; Apolipoprotein C-III/Apolipoprotein C-III/Apolipoprotein C-III/*genetics ; Coronary Disease/Coronary Disease/Coronary Disease/*genetics

• Source: Nature reviews. Cardiology [Nat Rev Cardiol] 2014 Sep; Vol. 11 (9), pp. 496. Date of Electronic Publication: 2014 Jul 08.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500075 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Dyslipidaemia: Monoclonal antibody targeting lipoprotein-bound human apoC-III.

• Authors : Huynh, Karina

Subjects: *MONOCLONAL antibodies; *APOLIPOPROTEIN C; *TRIGLYCERIDES

• Source: Nature Reviews Cardiology. Nov2017, Vol. 14 Issue 11, p632-633. 2p.

Record details

TARGETING apoC-III TO LOWER TRIGLYCERIDES.

• Authors : Huynh, Karina

Subjects: *APOLIPOPROTEIN C; *TRIGLYCERIDES; *GENETIC disorders

• Source: Nature Reviews Cardiology. Feb2015, Vol. 12 Issue 2, p64-64. 1/3p.

Record details

APOC3 mutations lower CVD risk.

• Authors : Geach, Tim

Subjects: *APOLIPOPROTEIN C; *GENETIC mutation; *CORONARY heart disease risk factors

• Source: Nature Reviews Cardiology. Sep2014, Vol. 11 Issue 9, p496-496. 2/3p.

Record details

Inhibiting apoC-III synthesis in patients with hypertriglyceridaemia.

• Authors : Huynh, Karina

Subjects: *HYPERTRIGLYCERIDEMIA; *APOLIPOPROTEIN C; *BIOSYNTHESIS

• Source: Nature Reviews Cardiology. Oct2015, Vol. 12 Issue 10, p562-562. 1/2p.

Record details

Apolipoproteins in vascular biology and atherosclerotic disease

• Authors : Mehta, Anurag; Shapiro, Michael D.

• Source: Nature Reviews Cardiology; March 2022, Vol. 19 Issue: 3 p168-179, 12p

Record details

RNA interference lowers triglyceride levels

• Authors : Lim, Gregory B.

• Source: Nature Reviews Cardiology; August 2024, Vol. 21 Issue: 8 p522-522, 1p

Record details